Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • BW TV
  • Subscribe to Print

Latest Articles in dcgi

DCGI Gives Emergency Use Nod To SII's Covovax For 12-17 Years Age Group

It is the fourth vaccine to receive the regulator's nod for use among those below 18 years

Read More

Natco Pharma Signs Agreement With MPP To Sell Molnupiravir Capsules

Natco Pharma Ltd said it has signed a non-exclusive license agreement with the Medicines Patent Pool (MPP), Switzerland to manufacture and sell Molnupiravir capsules 200 mg for treatment of COVID-19.

Read More

Govt Expert Panel Recommends Regular Market Approval For Covishield, Covaxin

Pharma companies Serum Institute of India (SII) and Bharat Biotech had submitted applications to the Drugs Controller General of India (DCGI) seeking regular market authorisation for their respective COVID-19 vaccines Covishield and Covaxin.

Read More

Stempeutics Gets DCGI Nod For Phase 3 Trial For COVID Treatment

The company will be using its stem cell product, Stempeucel, for conducting the label extension Phase 3 clinical trial.

Read More

After Serum, Bharat Biotech Seeks Regular Marketing Approval For Covaxin

DCGI had asked for some more information following which Singh last week submitted a response along with all desired data and information to DCGI.

Read More

Pharma Firms To Roll Out Anti-Covid Pill As DCGI Approves Emergency Use

They plan to market the capsules under their respective brands and make them available at all leading pharmacies and COVID-treatment centres across the country.

Read More

Cadila Healthcare Gets DCGI Nod To Conduct Phase III Trials For Two-Dose COVID Vaccine

Shares of Cadila Healthcare Ltd were trading at Rs 563.95 per scrip on BSE, up 0.29 percent from their previous close

Read More

Novavax, SII Apply To WHO For Emergency Use Listing Of COVID Vaccine

The application to WHO is based on the companies' previous regulatory submission to the Drugs Controller General of India (DCGI), Novavax Inc said in a statement.

Read More

Mankind Pharma Gets DRDO Nod To Manufacture, Market Covid Drug 2-DG

The clinical trials for 2-DG were conducted by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of DRDO, in association with Dr Reddy’s Laboratories

Read More

Johnson & Johnson Exploring Ways To Accelerate Delivery Of Its COVID Vaccine In India

The company also said as per a recent announcement by the Indian drug regulator, there is no longer a need to conduct bridging clinical trials of COVID-19 vaccines in India.

Read More

Sun Pharma To Launch Complete Range Of Generic Anti-Epilepsy Drug

Brivaracetam belongs to the class of anti-epileptic drugs (AEDs) which have a unique or different mechanism of action compared to the existing treatment options. It has fast onset of action and promising efficacy.

Read More

New Thermo Fisher Scientific Manufacturing Facility to produce reliable COVID-19 testing kits in India for India

New Thermo Fisher Scientific Manufacturing Facility to produce reliable COVID-19 testing kits in India for India

Read More

Enzene Biosciences Ltd. obtains marketing authorization for its first biosimilar molecule in India

Enzene Biosciences Ltd. obtains marketing authorization for its first biosimilar molecule in India

Read More

Bharat Biotech seeks DCGI's nod to conduct trials of nasal COVID-19 vaccine

Bharat Biotech seeks DCGI's nod to conduct trials of nasal COVID-19 vaccine

Read More

Our goal is to provide global access of Covaxin to needy population: Dr Ella

Our goal is to provide global access of Covaxin to needy population: Dr Ella

Read More